Reuters took readers on a deep dive into how U.S. states, cities and hospitals are scrambling to buy ultra-cold freezers that can safely store Pfizer Inc’s COVID-19 vaccine, ignoring advice from the U.S. Centers for Disease Control and Prevention to hold off. The push reveals a lack of infrastructure to support a super cold vaccine campaign, including equipment to store millions of doses of Pfizer’s vaccine at temperatures of minus 70 degrees Celsius (minus 94°F). And it has thrown a spotlight on makers of the niche freezers, which are adding labor and expanding capacity.
Health
Reuters reveals U.S. states racing to buy ultra cold vaccine freezers, fueling supply worries
13 November 2020, 4:32 pm 1 minute
Article Tags
Topics of Interest: Health
Type: Reuters Best
Regions: North America
Win Types: Exclusivity
Story Types: Special Report / Insight
Media Types: Text
Customer Impact: Important Regional Story